CompuMed, Inc.

CompuMed, Inc.

CMPD
CompuMed, Inc.US flagOther OTC
6.75
USD
- -
- -
8.71MMarket Cap
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
TTM
Revenue per Share
3.66
2.77
2.7
2.74
2.53
2.54
2.72
2.23
2.25
2.12
1.98
1.64
- -
1.54
Basic EPS, GAAP
-1.75
-2.09
-1.25
-0.69
-0.52
-0.38
-0.4
-0.45
-1.4
-1.46
-0.24
-0.35
- -
-0.2
Free Cash Flow per Basic Share
-1.75
-2.26
-1.18
-0.43
-0.13
-0.3
-0.31
-0.33
-0.64
-1.02
-0.08
-0.13
- -
-0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-45.5
-43.41
-43.27
-43.96
-44.46
-43.82
-38.59
-34.56
-34.73
-35.1
-34.69
-33.89
- -
-33.54
Tangible Book Value per Share
4.61
3.25
1.89
1.14
0.64
0.62
0.87
0.75
1.53
0.58
0.41
0.19
- -
-0.01
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
1
1
- -
1
Sales/Revenue/Turnover
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Operating Margin (%)
-47.83
-83.22
-49.46
-31.1
-23.3
-18.91
-15.94
-21.43
-48.56
-64.51
-9.86
-19.75
-17.97
-17.97
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
-1
- -
- -
- -
- -
- -
-1
-1
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-47.83
-75.54
-46.55
-25.27
-20.71
-14.82
-14.71
-20.06
-62.27
-68.65
-12.35
-21.45
-13.27
-13.27
Working Capital
2
1
1
- -
- -
- -
1
1
1
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
3
2
1
1
1
1
1
1
2
1
1
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'11
Jun'11
Sep'11
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
3
2
1

Working Capital

FRC

in mil. unless spec.
Mar'11
Jun'11
Sep'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-10.28%
-17.16%
-65.06%
Free Cash Flow
12.54%
16.51%
-72.22%
Net Income, GAAP
11.08%
31.62%
-41.01%
Sales/Revenue/Turnover
-0.93%
-4.29%
-4.6%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
1
1
- -
- -
2
2010
- -
- -
- -
- -
2
2011
- -
- -
- -
- -
2

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
-0.14
- -
-0.05
- -
-0.24
2010
-0.15
-0.06
-0.08
- -
-0.35
2011
-0.11
-0.07
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Lee Keddie
Full Time Employees
8
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
5777 West Century Boulevard Los Angeles CA United States of America 90045
IPO Date
May 28, 1987
Business
CompuMed, Inc. (CMPD) provides diagnostic telemedicine solutions that deliver on-demand access to U.S. board-certified physician specialists via secure cloud-based technology and integrated medical devices; its core offerings include telecardiology services such as EKG/ECG and echocardiogram (ECHO) interpretations, teleradiology, telepathology, and pulmonology diagnostic readings; the company supports multi-modality image management, STAT interpretations within 30-120 minutes, structured reporting, EMR/PACS integration, and 24/7 customer support for high-acuity workflows. CompuMed serves over 1,000 clinical settings worldwide, including hospitals, urgent care centers, occupational health clinics, surgical centers, organ procurement organizations, rural clinics, correctional facilities, and U.S. federal and state government branches; it targets high-urgency environments focused on cardiovascular disease, high-incidence conditions, and subspecialty diagnostics. Founded in 1973 or 1986 and headquartered at 5777 West Century Boulevard, Suite 360, in Los Angeles, California, the Delaware-incorporated company operates as a public entity traded on the OTCPink exchange. In recent developments, CompuMed repurchased shares from VI Capital and implemented changes to its board of directors in June 2023, enhancing governance stability; the company continues to emphasize "Integration-as-a-Service" for seamless technology adoption and workflow optimization amid evolving healthcare systems.

Company News

APIChat
  • CompuMed (OTCMKTS:CMPD) & Trinity Biotech (NASDAQ:TRIB) Head-To-Head Review

  • CompuMed (OTCMKTS:CMPD) Trading 7.1% Higher – Still a Buy?

  • CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and Transplantation

  • CompuMed Expands Cardiology Services to Rural and Regional Hospitals, Revolutionizing Patient Care

  • CompuMed Integrates the Techcyte Digital Pathology Reviewing Platform to Help Increase Transplanted Organs

  • Natalia Suero believed son was ‘possessed’: Cops

  • Akingbiwaju Opadele charged with sexual assault of teen